Geode Capital Management
AKCA

Geode Capital Management’s Akcea Therapeutics Inc AKCA Stock Holding History

Geode Capital Management’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-317,000
Closed -$5.75M – 4350
2020
Q3 		$5.75M Sell
317,000
-13,979
-4% -$198K ﹤0.01% 2309
2020
Q2 		$4.53M Buy
330,979
+58,959
+22% +$910K ﹤0.01% 2390
2020
Q1 		$3.89M Buy
272,020
+20,629
+8% +$339K ﹤0.01% 2284
2019
Q4 		$4.26M Sell
251,391
-5,920
-2% -$110K ﹤0.01% 2556
2019
Q3 		$3.96M Buy
257,311
+10,991
+4% +$234K ﹤0.01% 2521
2019
Q2 		$5.78M Buy
246,320
+5,523
+2% +$136K ﹤0.01% 2296
2019
Q1 		$6.82M Buy
240,797
+15,763
+7% +$459K ﹤0.01% 2143
2018
Q4 		$6.78M Buy
225,034
+15,950
+8% +$447K ﹤0.01% 2035
2018
Q3 		$7.32M Buy
209,084
+5,953
+3% +$180K ﹤0.01% 2130
2018
Q2 		$4.82M Sell
203,131
-4,008
-2% -$95.7K ﹤0.01% 2345
2018
Q1 		$5.3M Buy
207,139
+2,599
+1% +$55.9K ﹤0.01% 2201
2017
Q4 		$3.55M Buy
204,540
+3,147
+2% +$61.7K ﹤0.01% 2421
2017
Q3 		$5.57M Buy
+201,393
New +$3.73M ﹤0.01% 2139

Geode Capital Management's AKCA Position: Q4 2020 in Review

Geode Capital Management sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 317,000 shares — an estimated $5.75M sold.

Geode Capital Management first reported a position in AKCA in Q3 2017 and held it in 13 quarters. The position peaked at $7.32M in Q3 2018. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • Geode Capital Management reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • Geode Capital Management sold 317,000 Akcea Therapeutics Inc shares in Q4 2020, an estimated $5.75M.
  • Geode Capital Management first reported a position in Akcea Therapeutics Inc in Q3 2017 and held it in 13 quarters.
  • Geode Capital Management's Akcea Therapeutics Inc position peaked at $7.32M in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Geode Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.